Clinical trial
Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa)…
NCT00452686 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00452686 |
|---|---|
| Title | Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine |
| Official title | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix (dTpa) Vaccine and the Chinese DT Vaccine, When Administered as Booster Vaccination in Healthy Children Aged 6-8 Years |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diphtheria, Acellular Pertussis, Tetanus |
| Intervention type | Biological |
| Interventions | Boostrix, Chinese DT vaccine |
| Enrollment | 660 |
| Start date | Mar 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Mar 27, 2007 |
| Last update posted | Oct 28, 2016 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: